$SNYR

Synergy CHC Corp.

No enriched coverage for $SNYR in the last 7 days.

No SEC Form 4 filings for $SNYR in the last 30 days.

Low

Synergy CHC Corp. (SNYR): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Synergy CHC Corp. (SNYR) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001562733 0001562733 2026-06-29 2026-06-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Repor

[ARS] Synergy CHC Corp. SEC Filing

This article announces an SEC filing (Form ARS) by Synergy CHC Corp. (SNYR) on April 30, 2026, at 4:18 PM. The filing is categorized with low impact and neutral sentiment, and a PDF document is available for viewing. The article also provides a brief overview of SNYR's stock, market cap ranking, recent news, and other SEC filings.

Massive equity plan, warrant and reverse split up for Synergy CHC (SNYR) vote

Synergy CHC Corp. (SNYR) is seeking stockholder approval for several key proposals at its 2026 virtual annual meeting on June 29, 2026. These include electing directors, ratifying auditors, significantly increasing its 2024 Equity Incentive Plan share reserve to 150,000,000 common shares and allowing repricing of awards, approving the full issuance of shares under a Lender Warrant for Nasdaq compliance, and authorizing a reverse stock split at a ratio of up to 1-for-200. These proposals aim to increase capital flexibility, maintain Nasdaq listing, and align executive and stockholder interests, despite potential dilution concerns and a reported net loss of $(12.3) million in 2025.

SNYR sentiment & insider activity

Recent SNYR coverage spans financial news and corporate actions.

What's driving SNYR

  • Board/stockholder approvals expand equity plan capacity and permit repricing, which can affect dilution expectations and executive/employee compensation optics.

    SEC EDGAR 8-K · Jun 29, 2026

  • The recent SEC filing (Form ARS) by SNYR is categorized with low impact and neutral sentiment, indicating minimal immediate effect on stock price or market perception.

    Stock Titan · May 1, 2026

  • The proposals aim to significantly increase share reserves and authorize a reverse split, which could lead to dilution and impact stock price stability. The net loss and dilution concerns may exert bearish pressure, but the increased capital flexibility could benefit long-term strategic growth.

    Stock Titan · May 1, 2026

  • The delay in filing and balance sheet stress suggest potential short-term operational challenges, which may lead to a cautious market response. Despite improved profitability, negative cash flow and financial uncertainties could weigh on stock performance.

    TipRanks · Apr 1, 2026

  • The scheduled earnings release and investor call on April 1, 2026, could lead to increased trading activity in SNYR. Positive results may boost the stock, while disappointing earnings could lead to declines.

    Stock Titan · Mar 31, 2026

alphai scores every news story that mentions SNYR with an AI model for sentiment and relevance, and aggregates insider trades from Synergy CHC Corp.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $SNYR

Score
$SNYRLow

Synergy CHC Corp. (SNYR): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Synergy CHC Corp. (SNYR) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001562733 0001562733 2026-06-29 2026-06-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Repor

$SNYRLow

[ARS] Synergy CHC Corp. SEC Filing

This article announces an SEC filing (Form ARS) by Synergy CHC Corp. (SNYR) on April 30, 2026, at 4:18 PM. The filing is categorized with low impact and neutral sentiment, and a PDF document is available for viewing. The article also provides a brief overview of SNYR's stock, market cap ranking, recent news, and other SEC filings.

$SNYRMed

Massive equity plan, warrant and reverse split up for Synergy CHC (SNYR) vote

Synergy CHC Corp. (SNYR) is seeking stockholder approval for several key proposals at its 2026 virtual annual meeting on June 29, 2026. These include electing directors, ratifying auditors, significantly increasing its 2024 Equity Incentive Plan share reserve to 150,000,000 common shares and allowing repricing of awards, approving the full issuance of shares under a Lender Warrant for Nasdaq compliance, and authorizing a reverse stock split at a ratio of up to 1-for-200. These proposals aim to increase capital flexibility, maintain Nasdaq listing, and align executive and stockholder interests, despite potential dilution concerns and a reported net loss of $(12.3) million in 2025.

$SNYRMed

Synergy CHC delays annual Form 10-K filing

Synergy CHC has announced a delay in filing its annual Form 10-K for the fiscal year ended December 31, 2025, due to ongoing work on its financial statements. The company expects to submit the report within the 15-day extension period and does not anticipate significant changes in operating results. TipRanks' AI Analyst, Spark, rates SNYR as Neutral due to balance sheet stress and negative cash generation, despite improved profitability and a low P/E valuation.

$SNYRMed

Synergy CHC pushes earnings release and investor call to April 1

Synergy CHC Corp. (NASDAQ: SNYR) has announced a revised date for its fourth quarter and full-year 2025 financial results, moving the release to Wednesday, April 1, 2026, before market open. A conference call with CEO Jack Ross and CFO Jaime Fickett will follow at 9:00 a.m. ET. The company will discuss its financial performance and provide updates to investors during the call.

SYNERGY CHC (NASDAQ:SNYR) Featured on “New to The Street” - Bloomberg Television, Saturday, November 1st at 6:30 PM ET

Synergy CHC Corp. (NASDAQ:SNYR) will be featured on Bloomberg Television's "New to The Street" on Saturday, November 1st, at 6:30 PM ET. The segment will highlight the company's growth, innovative marketing, and expanding retail presence for its Focus Factor® brand and other wellness products. This appearance aims to provide viewers with insights into Synergy's role in the health and performance supplement market and its future expansion strategies.

Related tickers